Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 26-week treatment, multi center, randomized, double blind, double dummy, placebo controlled, parallel group study to assess the efficacy and safety of indacaterol (150 μg o.d.) in patients with chronic obstructive pulmonary disease, using salmeterol (50 μg b.i.d.) as an active control https://www.kusajili.fr:443/Trial/cnLgQi4AOEKlTLXZARj5hw%24a-26-week-treatment-multi-center-randomized-double-blind-double-dummy-placebo-controlled-parallel-group-study-to-assess-the-eff
I have read and accept the terms of use of the site and the Privacy Policy
Send your message